The purchase, establishment and screening of compound libraries is a key first step in the identification of hit compounds.
Our parent company, Viva Biotech has designed a compound library that is guided by the structural diversity, physicochemical characteristics, druggability, and solubility of the compounds incorporated. This large, diverse library is continuously optimised by a team of medicinal chemistry, computational chemistry and hit discovery experts. In addition, Viva has a range of advanced screening technologies, which can be used to screen either the Viva large diversity compound library, other Viva libraries, which include two Fragment libraries (totalling 3000 compounds), a GPCR-focused library (with 6500 compounds) a recently created covalent library (with 1000 compounds), as well as compound libraries which are provided by our clients for their projects.
We are able to utilise the following screening technologies to discover hit compounds;
Crystal Soaking Technology
Our other services
Medicinal ChemistryFind out more
Synthetic Chemistry & Custom SynthesisFind out more
Integrated Drug DiscoveryFind out more
PROTACs & Molecular GluesFind out more
Antibody Drug ConjugatesFind out more
Protein Production & Structural BiologyFind out more
Can’t see what you’re looking for? Please get in touch
We love to talk about Discovery Chemistry
Email or fill in the form opposite and our dedicated team will get back to you as soon as possible.E. firstname.lastname@example.org